| Financial Year |
March 31 2023 |
| Monetary Funds |
1,715,678,000.85 |
| Held-for-trading Financial Assets |
93,529,652.12 |
| Notes Receivable |
-- |
| Accounts Receivable |
347,387,145.03 |
| Advances to Suppliers |
70,863,764.37 |
| Other Receivables |
70,556,156.74 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
2,061,510.00 |
| Dividend Receivable |
8,757,447.00 |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
424,719,638.16 |
| Total Current Assets |
2,722,734,357.27 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
596,964,550.75 |
| Investment Properties |
55,965,539.93 |
| Fixed Assetes |
619,578,127.88 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
281,031,010.28 |
| R&D expenses |
281,784,215.81 |
| Goodwill |
202,141,681.19 |
| Long-Term Deferred and Prepaid Expenses |
28,732,449.30 |
| Deferred Income Tax Assets |
27,145,525.32 |
| Other Non-Current Assets |
68,367,885.29 |
| Sub-Total of Non-Current Assets |
3,707,838,404.99 |
| Total Assets |
6,430,572,762.26 |
| Short-Term Loans |
424,388,149.30 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
484,817,511.08 |
| Accounts Received In Advance |
26,323.82 |
| Employee Compensation Payable |
92,481,658.24 |
| Taxes Payable |
34,292,150.88 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
29,042,697.02 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,932,980.02 |
| Other Current Liabilities |
11,507,071.12 |
| Sub-Total of Current Liabilities |
1,224,330,274.98 |
| Long-term Loans |
-- |
| Bonds Payable |
627,030,270.99 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
4,500,000.00 |
| Deferred Income Tax Liabilities |
39,628,964.99 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
680,103,189.16 |
| Total Liabilities |
1,904,433,464.14 |
| Paid-In Capital(Or Share Stock) |
915,871,399.00 |
| Capital Surplus |
1,092,894,560.68 |
| Surplus Reserve |
70,824,673.48 |
| LESS:Treasury Stock |
366,860,548.89 |
| Undistributed Profits |
2,699,748,987.78 |
| Minority Stockholder's Interest |
-23.35 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,526,139,321.47 |
| Owner's Equity（Stockholder's Equity） |
4,526,139,298.12 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,430,572,762.26 |
